Metamizole
Metamizole (also known as dipyrone) is a non-opioid analgesic and antipyretic medicine used in some countries to manage moderate to severe pain and high fever when other treatments are unsuitable or ineffective. It works through mechanisms involving prostaglandin pathways and central pain-processing systems, although its exact mechanism is not fully understood. It is available in tablets, oral drops, and injectable formulations, depending on the country. Possible side effects include nausea, dizziness, and allergic reactions; a rare but serious risk is agranulocytosis, a potentially life-threatening reduction in white blood cells. Metamizole is restricted or not approved in some countries because of this risk, and patients should seek urgent medical attention for fever, sore throat, or mouth ulcers during treatment. It should be used only where approved and under appropriate medical supervision.
Metamizole was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:
is okay
The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.
Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Metamizole, subject to confirmation of its current regulatory status and eligibility for import into India.
The export of Metamizole from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.
Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Metamizole, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.
If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.
